Cargando…

Corrigendum: Exploring the pharmacological mechanisms of icaritin against nasopharyngeal carcinoma via network pharmacology and experimental validation

Detalles Bibliográficos
Autores principales: Liu, Minglu, Hu, Tong, Gou, Wenfeng, Chang, Huajie, Li, Yanli, Li, Yiliang, Zuo, Daiying, Hou, Wenbin, Jiao, Shunchang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9927636/
https://www.ncbi.nlm.nih.gov/pubmed/36798079
http://dx.doi.org/10.3389/fphar.2023.1140018
_version_ 1784888507421949952
author Liu, Minglu
Hu, Tong
Gou, Wenfeng
Chang, Huajie
Li, Yanli
Li, Yiliang
Zuo, Daiying
Hou, Wenbin
Jiao, Shunchang
author_facet Liu, Minglu
Hu, Tong
Gou, Wenfeng
Chang, Huajie
Li, Yanli
Li, Yiliang
Zuo, Daiying
Hou, Wenbin
Jiao, Shunchang
author_sort Liu, Minglu
collection PubMed
description
format Online
Article
Text
id pubmed-9927636
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-99276362023-02-15 Corrigendum: Exploring the pharmacological mechanisms of icaritin against nasopharyngeal carcinoma via network pharmacology and experimental validation Liu, Minglu Hu, Tong Gou, Wenfeng Chang, Huajie Li, Yanli Li, Yiliang Zuo, Daiying Hou, Wenbin Jiao, Shunchang Front Pharmacol Pharmacology Frontiers Media S.A. 2023-01-31 /pmc/articles/PMC9927636/ /pubmed/36798079 http://dx.doi.org/10.3389/fphar.2023.1140018 Text en Copyright © 2023 Liu, Hu, Gou, Chang, Li, Li, Zuo, Hou and Jiao. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Liu, Minglu
Hu, Tong
Gou, Wenfeng
Chang, Huajie
Li, Yanli
Li, Yiliang
Zuo, Daiying
Hou, Wenbin
Jiao, Shunchang
Corrigendum: Exploring the pharmacological mechanisms of icaritin against nasopharyngeal carcinoma via network pharmacology and experimental validation
title Corrigendum: Exploring the pharmacological mechanisms of icaritin against nasopharyngeal carcinoma via network pharmacology and experimental validation
title_full Corrigendum: Exploring the pharmacological mechanisms of icaritin against nasopharyngeal carcinoma via network pharmacology and experimental validation
title_fullStr Corrigendum: Exploring the pharmacological mechanisms of icaritin against nasopharyngeal carcinoma via network pharmacology and experimental validation
title_full_unstemmed Corrigendum: Exploring the pharmacological mechanisms of icaritin against nasopharyngeal carcinoma via network pharmacology and experimental validation
title_short Corrigendum: Exploring the pharmacological mechanisms of icaritin against nasopharyngeal carcinoma via network pharmacology and experimental validation
title_sort corrigendum: exploring the pharmacological mechanisms of icaritin against nasopharyngeal carcinoma via network pharmacology and experimental validation
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9927636/
https://www.ncbi.nlm.nih.gov/pubmed/36798079
http://dx.doi.org/10.3389/fphar.2023.1140018
work_keys_str_mv AT liuminglu corrigendumexploringthepharmacologicalmechanismsoficaritinagainstnasopharyngealcarcinomavianetworkpharmacologyandexperimentalvalidation
AT hutong corrigendumexploringthepharmacologicalmechanismsoficaritinagainstnasopharyngealcarcinomavianetworkpharmacologyandexperimentalvalidation
AT gouwenfeng corrigendumexploringthepharmacologicalmechanismsoficaritinagainstnasopharyngealcarcinomavianetworkpharmacologyandexperimentalvalidation
AT changhuajie corrigendumexploringthepharmacologicalmechanismsoficaritinagainstnasopharyngealcarcinomavianetworkpharmacologyandexperimentalvalidation
AT liyanli corrigendumexploringthepharmacologicalmechanismsoficaritinagainstnasopharyngealcarcinomavianetworkpharmacologyandexperimentalvalidation
AT liyiliang corrigendumexploringthepharmacologicalmechanismsoficaritinagainstnasopharyngealcarcinomavianetworkpharmacologyandexperimentalvalidation
AT zuodaiying corrigendumexploringthepharmacologicalmechanismsoficaritinagainstnasopharyngealcarcinomavianetworkpharmacologyandexperimentalvalidation
AT houwenbin corrigendumexploringthepharmacologicalmechanismsoficaritinagainstnasopharyngealcarcinomavianetworkpharmacologyandexperimentalvalidation
AT jiaoshunchang corrigendumexploringthepharmacologicalmechanismsoficaritinagainstnasopharyngealcarcinomavianetworkpharmacologyandexperimentalvalidation